Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 262

The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.

Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

Open access
Shahryari, Alireza, Saghaeian Jazi, Marie, Mohammadi, Saeed, Razavi Nikoo, Hadi, Nazari, Zahra, Hosseini, Elaheh Sadat, Burtscher, Ingo, Mowla, Seyed Javad, Lickert, Heiko·2019·Frontiers in Genetics

Abstract

The field of gene therapy is striving more than ever to define a path to the clinic and the market. Twenty gene therapy products have already been approved and over two thousand human gene therapy clinical trials have been reported world-wide. These advances raise great hope to treat devastating rare and inherited diseases as well as intractable illnesses. Gene therapy is presently starting to become commercially profitable as a number of gene and cell-based gene therapy products have been approved and have entered the market and the clinic. Understanding the precise pathomechanisms of diseases as well as emerging efficient and specific gene targeting and delivery tools are revolutionizing the global market. Currently, human cancers and monogenic disorders are indications number one. The elevated prevalence of genetic disorders and cancers, clear gene manipulation guidelines, as well as increasing financial support for gene therapy in clinical trials are major trends. This article addresses the history and development of twenty approved human gene and cell-based gene therapy products that have been approved up-to-now in clinic and markets of mainly North America, Europe and Asia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2019.00868

Cites

184 of 184 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 184 references

Cited by

See all 262

Metadata

Authors
Shahryari, A., Saghaeian Jazi, M., Mohammadi, S., Razavi Nikoo, H., Nazari, Z., Hosseini, E. S., Burtscher, I., Mowla, S. J., & Lickert, H.
Venue
Frontiers in Genetics
Published
2019-09-25
Volume
10
Pages
868-868
ISSN
1664-8021 (ISSN-L)
OpenAlex
W2969783143
Cited by
262
References
184
FWCI
18.01
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders. https://app.cochat.ai/papers/10.3389/fgene.2019.00868
The paper
Shahryari, A., Saghaeian Jazi, M., Mohammadi, S., Razavi Nikoo, H., Nazari, Z., Hosseini, E. S., Burtscher, I., Mowla, S. J., & Lickert, H. (2019). Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders. Frontiers in Genetics. https://doi.org/10.3389/fgene.2019.00868

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.